HAVCR2 and COVID-19: A study examining TIM3 expression in 44 COVID-19 patients (17 critical and 27 non-critical) and 14 healthy individuals revealed that critical patients had significantly higher levels of CD8+ TIM3+ lymphocytes than non-critical patients and healthy individuals.